Alliance Pharmaceutical Corp.
Alliance Pharmaceutical Corp. (Alliance) is a pharmaceutical research and development company. The company focuses on transforming innovative scientific discoveries into novel therapeutic and diagnostic agents. The Research and Development activity of the company is principally into the development of Oxygent an intravascular oxygen carrier designed to augment delivery in surgical patients. The company has three subsidiaries namely, Molecular Biosystems Inc. which is wholly owned; Talco Pharmaceutical , Inc. and PFC Therapeutics, LLC. Alliance operates in the U.S. and is headquartered in California, the US.
The company recorded revenues of USD 79 thousand during the fiscal year ended June 2009, a decrease of 25.47% over 2008. The operating loss of the company was USD 686 thousand during the fiscal year 2009, as compared to an operating loss of USD 1,101 thousand during 2008. The net loss of the company was USD 1,203 thousand during the fiscal year 2009, as compared to a net loss of USD 1,780 thousand during 2008.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

